Hereditary Angioedema Therapeutic Market Forecast: US$ 14.19 Bn by...

added blog Whats New

2024-03-15 04:19:32 -

Hereditary Angioedema Therapeutic Market Forecast: US$ 14.19 Bn by 2029, 16.79% CAGR, Key Players Include BioCryst Pharmaceuticals, Ionis Pharmaceuticals, and More

Hereditary Angioedema Therapeutics Market Poised for Growth at 16.79% CAGR, Driven by Rising Awareness and Treatment Advancements the global Hereditary Angioedema (HAE) therapeutics market is projected to reach US$ 14.19 billion by 2029, reflecting a robust compound annual growth rate (CAGR) of 16.79%. This press release highlights key findings from a new market report by Maximize Market...

0 Comments 0 Shares 2K Views